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Abstract
Background: Due to outdoor and residual transmission and insecticide resistance, long-lasting insecticidal nets
(LLINs) and indoor residual spraying (IRS) will be insufficient as stand-alone malaria vector control interventions in
many settings as programmes shift toward malaria elimination. Combining additional vector control interventions
as part of an integrated strategy would potentially overcome these challenges. Larval source management (LSM)
and structural house improvements (HI) are appealing as additional components of an integrated vector management
plan because of their long histories of use, evidence on effectiveness in appropriate settings, and unique modes of
action compared to LLINs and IRS. Implementation of LSM and HI through a community-based approach could
provide a path for rolling-out these interventions sustainably and on a large scale.
Methods/design: We will implement community-based LSM and HI, as additional interventions to the current national
malaria control strategies, using a randomised block, 2 × 2 factorial, cluster-randomised design in rural, southern Malawi.
These interventions will be continued for two years. The trial catchment area covers about 25,000 people living in 65
villages. Community participation is encouraged by training community volunteers as health animators, and supporting
the organisation of village-level committees in collaboration with The Hunger Project, a non-governmental organisation.
Household-level cross-sectional surveys, including parasitological and entomological sampling, will be conducted on a
rolling, 2-monthly schedule to measure outcomes over two years (2016 to 2018). Coverage of LSM and HI will also be
assessed throughout the trial area.
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Discussion: Combining LSM and/or HI together with the interventions currently implemented by the Malawi
National Malaria Control Programme is anticipated to reduce malaria transmission below the level reached by
current interventions alone. Implementation of LSM and HI through a community-based approach provides an
opportunity for optimum adaptation to the local ecological and social setting, and enhances the potential for
sustainability.
Trial Registration: Registered with The Pan African Clinical Trials Registry on 3 March 2016, trial number
PACTR201604001501493.
Keywords: Anopheles mosquitoes, Integrated vector management, Larval source management, House
improvement, Vector control, Malaria transmission, Community participation
Background
The main interventions currently recommended and
used for malaria control in endemic regions are diagno-
sis and treatment with effective drugs (e.g. artemisinin-
based combination therapies; ACTs), preventative ther-
apy (e.g. intermittent preventative therapy in pregnant
women; IPTp), and vector control with insecticide-
treated nets (ITNs) and indoor residual spraying (IRS).
These interventions have been clearly documented to be
effective at reducing malaria burden when population-
level coverage and use are high [1–4]. The halving of
Plasmodium falciparum prevalence and the prevention
of around 600 million clinical cases of malaria in en-
demic regions of Africa between 2000 and 2015 has been
attributed to the mass implementation of ACTs, ITNs
and/or IRS [5]. Vector control contributed to more than
70% of this reduction, demonstrating the importance of
interrupting mosquito-human contact in the fight
against malaria.
Despite these tremendous gains at controlling malaria
in both low- and high-transmission settings, there are a
number of well-documented challenges limiting the con-
tinued impact of the current interventions. Achieving
and sustaining high access and use has proven difficult
in most settings [6-8] due to inadequate infrastructure
[9–11], lack of funding [8, 11, 12], durability and attri-
tion in the case of ITNs [13, 14], and potential barriers
related to knowledge, behaviour and/or attitudes of the
target population [15–18]. Even with sustained high
coverage, currently-recommended interventions alone
are unlikely to eliminate malaria in high transmission
settings [19, 20], or where part of the mosquito vector
population bites or rests outdoors [21–24]. The develop-
ment of resistance to anti-malaria drugs and insecticides
by malaria parasite populations [25, 26] and vector popula-
tions [27, 28], respectively, poses yet further challenges.
The global community therefore continues to search
for new, innovative solutions for malaria control [29].
One approach getting more attention over the past
decade is the integration of multiple interventions, tar-
geting the disease from multiple directions and therefore
potentially leading to additive or synergistic effects be-
yond that of any single method on its own [30–33]. Inte-
grated methods are well established for the control of
insects, weeds and diseases in agriculture [34], providing
a reliable framework for the development of integrated
control programmes in public health [35]. Combining
multiple methods has the additional, significant benefit
of delaying the development of drug resistance [36] and
insecticide resistance if applied as part of a resistance
management strategy [37].
Two methods that could be integrated into existing
National Malaria Control Programme (NMCP) strategies
are larval source management (LSM) and structural
house improvement (HI). Larval source management is
commonly defined as the management of water bodies
that are potential larval habitats of mosquitoes to pre-
vent the completion of development of the immature
stages [38–40]. Generally, there are four types of LSM:
habitat modification (a permanent alteration to the en-
vironment such as land reclamation); habitat manipula-
tion (a recurrent activity such as flushing of streams);
larviciding (the regular application of biological or
chemical insecticides to water bodies); and biological
control (the introduction of natural predators into water
bodies) [40]. LSM was part of successful malaria control
campaigns in the United States, Israel, and Italy [38],
and integral to eliminating the African malaria vector,
Anopheles gambiae, from Brazil and Egypt [40]. In more
recent controlled trials where LSM has been the primary
intervention, it has reduced malaria prevalence in some,
but not all, settings [39]. Indeed, knowledge about the
ecology of local malaria vector populations and imple-
mentation of LSM methods deemed suitable for the spe-
cific setting are two critical components for a successful
LSM programme [41].
Most currently available methods of LSM carry very lit-
tle or no risk of reduced effectiveness over time due to in-
secticide resistance. No insecticides are used for habitat
modification, habitat manipulation, and biological control.
The most common larvicides use bacteria of the genus
Bacillus, which produce multiple mosquito-specific toxins
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[42]. The use of multiple toxins at once reduces the select-
ive pressure for insecticide resistance, and there is very
little evidence of resistance developing in natural mos-
quito populations despite wide-spread use of Bacillus
thuringiensis israelensis (Bti) in the United States of
America, Europe, and elsewhere [42, 43]. If used as part of
an integrated control programme, the different biological
mode of action for Bti, compared with insecticides used in
ITNs and IRS, further limits the risk of mosquitoes devel-
oping resistance to Bacillus-based larvicides. Furthermore,
LSM targets both outdoor and indoor biting/resting mos-
quitoes equally (because it targets immature stages), a crit-
ical issue for addressing residual transmission [44–47].
Improved housing also has a long history of association
with reducing malaria transmission [48]. In regions where
malaria vectors bite indoors, improved housing reduces
malaria transmission by reducing mosquito entry into
houses [49–51]. Methods of house improvement include
plastering walls and ceilings, filling crevices and holes, and
screening eaves and windows of houses or sleeping
quarters [48, 51–53]. Improved housing resulting from
more favourable social and economic conditions is associ-
ated with less malaria, even when reducing mosquito
entry is not necessarily the primary goal of the housing
design [54, 55]. House improvement as an intentional
intervention has been shown to reduce the number of
Anopheles mosquitoes indoors [51, 56], and reduce the
risk of anaemia in children [51]. As a malaria control
intervention, house improvement relies on a mechanical/
physical barrier, and does not, in principle, require any
insecticide to reduce house entry by mosquitoes. As a
physical barrier to reduce mosquito-human contact, it has
the advantage of being less dependent on individual use/
behaviour once it is in place. A further advantage is that it
can protect everyone inside a “treated” house.
Achieving high community coverage is a challenge for
currently-implemented and potential additional inter-
ventions alike. Focusing on community participation in
public health efforts is one approach for addressing this
challenge [57, 58]. Active community participation can
increase local programme ownership, encourage aware-
ness of health promotion, increase uptake of interven-
tions, and ultimately lead to reduced disease incidence or
prevalence [58–61]. Behaviour change communication
strategies can be an essential component of community
participation when introducing new interventions or
scaling-up current interventions. Vector control pro-
grammes, in particular, have a high potential for success
when community participation is explicitly incorporated
[32, 62–65].
Because LSM and HI target mosquitoes through
“modes of action” that are entirely different from ITNs
and IRS, these two interventions have a high potential to
complement existing intervention methods as part of an
integrated malaria control programme and lead to
additional reductions in malaria transmission. Consider-
ing this potential, we designed the trial described here
with the primary objective to determine the impacts of
HI and LSM on malaria parasite prevalence and ento-
mological inoculation rate (EIR) over a 24-month period,
when implemented alone or in combination, in addition
to the Malawi NMCP interventions. We explicitly as-
sume that NMCP interventions are implemented at the
Scale-up for Impact coverage targets [66], and we
explicitly implement both LSM and HI through a
community-based approach. We postulate the use of
LSM and/or HI in settings with high ITN and ACT use
will lead to additional reductions in malaria transmission
and burden on top of the effects from ITN and ACT
use. The design of the trial does not allow for testing the
potential for either LSM or HI to be used as a stand-
alone strategy, nor are we directly comparing the effect
of LSM or HI alone to the effect of ITN and ACT use.
Methods/Design
Study site
The study site is in Chikhwawa District, an area of high
malaria transmission in the Lower Shire River Valley
region of southern Malawi [67]. Chikhwawa is a mainly
rural area with a population of over 530,000 people
covering an area of about 4800 km2. Rain-fed farming is
the main occupation, with maize, millet and sorghum as
the major staple foods. Three malaria vector species are
present: Anopheles gambiae s.s., Anopheles arabiensis,
and Anopheles funestus [68]. Malaria control in
Chikhwawa follows guidelines set by the NMCP, and as
of 2015 relied on the use of ITNs (specifically, long-
lasting insecticidal nets; LLINs) and IPTp for prevention,
microscopy or rapid diagnostic tests (RDT) for diagno-
sis, and ACTs for treatment. Brands of LLIN distributed
by the NMCP include PermaNet® 2.0 (Vestergaard Frand-
sen, Lausanne, Switzerland), Olyset® Net (Sumitomo
Chemical Company, Tokyo, Japan), and as of 2016, Royal
Sentry® (Disease Control Technologies, USA). The cover-
age targets for these interventions, as defined by the
NMCP, are listed in Table 1. Poor roads and other infra-
structure are just some of the challenges faced by the
Chikhwawa District Health Office (DHO) in meeting
these goals. The NMCP implemented IRS in Chikhwawa
in 2010 and 2012 with alphacypermethrin [69]. Indoor re-
sidual spraying is not planned for the study site during the
trial period. Resistance to the pyrethroids used in LLINs
(permethrin and deltamethrin) has been reported for pop-
ulations ofAn. funestus, and to a lower extent, An. gam-
biae s.l., in Chikhwawa [69–71].
The trial villages are all located within the catchment
area of the Majete Malaria Project (MMP), a
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collaboration of the Ministry of Health, The Hunger
Project (THP; a non-governmental organisation specia-
lising in community-based programmes), African Parks-
Malawi (which has run the Majete Wildlife Reserve as
part of a public-private partnership since 2003), and the
academic institutions of the principal investigators of
this trial. The project aims to reduce the malaria burden
of the people living within about 10 km of Majete Wild-
life Reserve, indirectly serving conservation interests by
proposing that through improved health and socio-
economic conditions, the community will become a bet-
ter partner in natural resource management. The project
considers community engagement and participation as a
central focus of its strategy and follows THP’s principles
to implement behaviour change communication and
vector control programmes through a community-based
approach.
Since starting in 2014, MMP has initially concentrated
efforts in three regions, which we refer to as focal areas
A, B and C, respectively (Fig. 1). The three focal areas
are spaced roughly evenly around the wildlife reserve
and cover a total population of about 25,000 people in
65 villages. Focal areas were delineated to cover the
same villages as an existing or planned THP Epicentre,
which brings together neighbouring villages as a basis
for community-led development [72].
The health system serving the area consists of 1 dis-
trict referral hospital, 1 mission hospital, 1 private health
centre, 6 government health centres, 6 health posts and
12 village clinics.
We conducted an enumeration from August 2014
through February 2015, whereby for every household we
collected data on the name, gender, date of birth and re-
lationship to the head of household for each member of
the household. Here we defined a household as “a social
group made up of people eating from the same pot”.
Global positioning satellite (GPS) devices were used to
record the geo-location of each house (structure) in
which people slept at night, whereby the members of a
household (social group) could be split among multiple
houses (structure). Each house was given a unique
identification code, and a pre-printed label showing the
code was adhered to the door of the house immediately
following the survey. Data were electronically collected
and managed using a combination of Open Data Kit
(ODK) and OpenHDS software [73].
Community sensitisation and engagement
As implementing partners of MMP, staff from THP,
College of Medicine, African Parks, and the DHO were
responsible for sensitising the community about MMP in
general, and the trial specifically. Accordingly, meetings
were held separately at the District, Traditional Authority,
Group-Village, and Village administrative levels to engage
community leaders and stakeholders and sensitise them
about MMP and the upcoming trial. From there, commu-
nity engagement was an on-going process involving dis-
cussions between MMP staff, community leaders, and
community members at the focal area and village levels.
To encourage the use of existing, NMCP malaria
interventions, and to set the foundation for the
community-based implementation of the trial inter-
ventions, an “animator approach” adapted to the spe-
cific setting was used. Volunteers from the 65 villages
(slightly more than one per village on average) were
trained as “health animators” by MMP, and thereafter
these health animators led fortnightly malaria work-
shops in their communities. An essential component
of this approach is empowering the community
through a process of mindset change, leadership, vi-
sion, commitment and action [74]. In brief, this means
that the community should perceive malaria as a chal-
lenge that can be actively addressed, and it provides a
basis for community action planning towards malaria
control. Furthermore, health animators followed a train-
ing manual, developed by the project, to cover a broad
range of malaria topics at each of the community work-
shops. Following this approach, we expected that use of
NMCP malaria interventions was equal across all villages
in the trial. Still, this will be monitored via household
surveys, as explained below.
Table 1 Description of Malawi NMCP 2011–2015 SUFI targets [66]
Indicator Target
ITN ownership 90% of households own at least 1 ITN
ITN use by pregnant women 80% of pregnant women sleep under an ITN
ITN use by CU5 80% of CU5 sleep under ITN
IPTp 80% of pregnant women receive 2 or more doses of SP during pregnancy for malaria prevention
Case management 50% of suspected malaria cases at health care facilities confirmed by microscopy
Case management 80% of suspected malaria cases at health care facilities confirmed by RDT
Case management 50% of confirmed malaria cases appropriately treated within 24 h of onset of symptoms
CU5 children under 5 years of age, ITN insecticide-treated net, IPTp intermittent preventative therapy in pregnant women, NMCP National Malaria Control
Programme, RDT rapid diagnostic test, SUFI scale-up for impact
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Eligibility
Using village as the unit of randomisation, all house-
holds in the 65 enumerated villages were initially eligible
for coverage with the trial interventions, in principle.
Recognising the need for villages with different trial-
treatments to have some minimum distance separating
them to reduce the risk of contamination bias due to
mosquito flight [75], we randomly excluded some of the
eligible villages from the trial using the following ap-
proach. The objective of the approach was to identify a
set of villages within each enumerated focal area to in-
clude in the trial that: 1) minimised contamination bias;
2) minimised selection bias; 3) maximised statistical
power; and 4) gave every village at least one chance to
be included so as to maximise perceived fairness by the
participating communities. Within each focal area, we
started with a map of the enumerated villages and over-
laid 400 m buffer zones (Fig. 2) to identify which villages
violated our a priori definition of contamination distance
(i.e. any overlap of the 400 m buffer zones surrounding
each possible pair of 2 villages). The distance of 400 m
was determined after considering current knowledge
about dispersal of the dominant malaria vector mosquito
species in Africa [76]. While the maximum dispersal of
Anopheles mosquitoes may be up to several kilometres
under certain conditions, we also accounted for the rela-
tively high human population density of our study area
and assumed that the majority of Anopheles mosquitoes
here would disperse no more than a few hundred metres.
The maps of villages with overlaid buffer zones gave
us an initial set of clusters, which were defined as a set
of villages ranging in number from 1 to n, where n is the
number of villages with overlapping buffer zones. For
example, in Fig. 3a, there are 3 clusters. Due to the “nat-
ural layout” of village borders in some focal areas, in-
cluding all villages in the trial would have given fewer
clusters (N = 3) of more villages (maximum n = 19) than
desired for maximising statistical power. To address this,
we asked the question, “which villages should be ex-
cluded from the trial to give the maximum number of
clusters possible in each focal area?”; and we answered
the question using a solution from the mathematical
field of graphs (i.e. maximum statistical power with re-
striction to the focal area). Knowing the maximum pos-
sible number of clusters, Nmax, we “manually” found
alternative sets of villages which provided Nmax-1 to
Fig. 1 Study site map. Majete Wildlife Reserve, surrounded by 19 groups of villages known as community-based organisations (CBO). Trial villages
fall under 7 of these CBOs, representing the 3 focal areas, or blocks. All villages in these 7 CBOs were enumerated into a demographic surveillance
system (DSS). Reprinted with slight modification from Kabaghe et al. [90]
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Nmax clusters, and where the final list of sets included
every village in the focal area at least once (i.e. max-
imum perceived fairness by the participating communi-
ties; Figs. 3b-d). Finally, one set of villages was randomly
chosen in each focal area as the first stage of a 2-stage
community raffle drawing (i.e. to minimise selection
bias; Fig. 4)
Design
The trial follows a randomised block, 2 × 2 factorial de-
sign (Table 2), with the three focal areas covered by
MMP forming three blocks. The unit of randomisation
for allocation of trial arms is the village, though we re-
quire all villages in the same cluster (above) to be rando-
mised to the same treatment. The trial will run for two
years, starting from the mass distribution of LLINs com-
pleted by the NMCP and Chikhwawa District Health
Office on 1 May 2016.
Randomisation
There were two stages for the randomisation within each
focal area (Fig. 4), which took place at a community
event in each focal area to increase perceived fairness
and engagement on the part of the participating com-
munities. In the first stage, a set of villages was ran-
domly selected from among six sets of villages satisfying
the inclusion criteria described above. The six sets were
numbered from 1 to 6, six cards numbered 1 to 6 were
placed in a dish, and a volunteer from the community
blindly selected one card. The remaining sets of villages
were discarded. In one focal area (B) this stage was not
necessary because the set of all villages in the focal area
satisfied the inclusion criteria. From the set of included
villages, treatments were randomly allocated to clusters,
so that villages within a single cluster were randomised
to the same treatment. The four trial arms were num-
bered from 1 to 4, cards numbered 1 to 4 were placed in
a dish, and for each cluster a representative of the com-
munity selected one card to determine the treatment
assigned to the villages in that cluster.
Interventions
There are two interventions being evaluated in this trial:
LSM and HI. While LSM generally refers to four broad
types of activities [40], in this trial it refers specifically to
habitat modification and larviciding. In this setting
habitat modification refers to either draining or filling
water bodies with the aim of permanently eliminating
Anopheles larval habitats in cases where this is feasible
Fig. 2 Example showing how buffer zones were used to define contamination distance. Village A and Village B could not be assigned to
different treatments without risking contamination bias. Village C is assumed to be a sufficient distance from Villages A and B to limit
contamination bias
Table 2 Trial arms showing interventions
Arm NMCP LSM HI
1 √
2 √ √
3 √ √
4 √ √ √
HI house improvements, LSM larval source management, NMCP National
Malaria Control Programme. For a description of NMCP interventions and
target coverage, see Table 1
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and the water is not used for a specific community pur-
pose. Larviciding will be done on all remaining potential
Anopheles larval habitats with Bti, which are bacteria
that produce insecticidal crystal proteins that, when
ingested by larvae, attack the gut lining causing cessation
of feeding and subsequent mortality [42]. Using the
same “health animator approach” described above,
communities in LSM villages are being trained and en-
gaged in the concepts and practice of LSM. Following
the project-led training of the health animators, each
LSM village formed a LSM committee of 10–12 mem-
bers tasked with organising all LSM activities in the vil-
lage. For habitat modification, LSM committees and
community leaders encourage all community members
to participate in draining and filling potential larval habi-
tats, and no material inputs are provided by the project.
Additional training on the application of Bti was pro-
vided by the project to all LSM committee members to
implement the application of Bti in their respective
villages. Equipment and material (VectoBac WDG,
Valent Biosciences, Libertyville IL, USA) for Bti applica-
tion are provided by the project.
House improvement in this trial refers to material
modification of houses aimed at blocking entry of mal-
aria vectors. Following discussions with communities,
the agreed modifications consist of: closing all eaves (i.e.
where a wall meets the overhang of the roof ) using local
material similar to that used to construct the house (i.e.
bricks and extra mud for most houses); closing all holes
in the wall not used for ventilation using the same mate-
rials used for closing eaves; covering windows and other
openings used for ventilation with aluminium screens
that allow airflow; and modifying doors so as to fully
cover doorways when closed. Similar to LSM, communi-
ties in HI villages are being engaged in the concepts and
practices of HI through health animators and village-
level committees. The project trained health animators
on these concepts and practices, and then villages
formed their own HI committees to organise and follow
up on HI activities. In general, HI committees, commu-
nity leaders and health animators encouraged heads of
households in HI villages to carry out any necessary im-
provements on their own houses. When household
members were unable to improve their houses on their
Village border
Majete park border
Buffer zone 400m
A
B
C
D
E
Fig. 3 Random exclusion of villages. All five maps show the 21 villages of the focal area to the west of Majete Wildlife Reserve. a shows a 400 m
buffer overlaid on each of the 21 villages. Nineteen of the villages have overlapping buffers, while two villages are a sufficient distance from the
others to limit contamination bias. b and c highlight two different sets of villages that could be excluded from the trial intervention allocation, so
as to leave the clusters of villages shown in d and e, whereby clusters do not overlap with each other
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own, HI committees assisted them. Materials provided
by the project for HI were aluminium screening (allo-
cated to each household based on surface area to cover,
and distributed and managed by HI committees) and a
set of basic hand tools shared and managed by the HI
committees.
The coverage of LSM and HI in this trial depends
heavily on community engagement and participation
because the study design explicitly calls for community
implementation of the interventions. Strategies to
maximise “adherence”, and thus coverage, include the
animator approach described above, livelihood develop-
ment programmes (e.g. microfinance) implemented by
THP, and regular monitoring of coverage by project staff
with follow-ups. The animator approach is expected to
improve coverage through an increased understanding
of malaria, including the causes and mechanisms of
prevention for each intervention. Development pro-
grammes associated with THP’s epicentres may further
increase adherence by improving community engage-
ment with the project. Finally, project staff will monitor
coverage and encourage community-led corrective
measures.
Data collection
Mosquitoes will be sampled from the houses of study
participants using so-called Suna traps (Biogents AG,
Regensburg, Germany). The Suna trap is an odour-baited
mosquito trap recently developed to collect host-seeking
Anopheles mosquitoes both indoors and outdoors [77].
The trap uses CO2 produced through a process of yeast
and molasses fermentation [78] and a synthetic blend of
chemicals found on human skin [79] to attract mosqui-
toes. The odour blend used is standardised, allowing for
reliable comparisons among trapping locations both in-
doors and outdoors. Alternative sampling methods, such
as Centers for Disease Control and Prevention (CDC)
light traps or pyrethrum spray catch, are not designed for
outdoor use. In the case of CDC light traps, standard pro-
cedures for sampling African malaria vectors require the
trap to be placed next to a person sleeping under a bed
net [80].
Field teams will set up Suna traps at the houses of
study participants and collect the mosquitoes from the
traps each morning after a night of sampling. All mos-
quitoes collected will be preserved using a desiccant and
identified using standard morphological and molecular
Health animator trainings on 
malaria and NMCP interventions
Majete Wildlife Reserve Perimeter (182 villages)
Block A
21 villages
Block B
13 villages
Block C
31 villages
MMP catchment area (65 villages)
Grouped into 6 sets of villages
13-16 villages each
Grouped into 6 sets of villages
21-25 villages each
13 villages 
15 villages in randomly 
selected set
All 13 villages distributed with 
sufficient inter-village distance
25 villages in randomly 
selected set
6 villages excluded 
as buffers
6 villages excluded 
as buffers
Random 
selection of 1 set
Random 
selection of 1 set
NMCP only
2 villages
NMCP + LSM
2 villages
NMCP + HI
8 villages
NMCP + HI + LSM
3 villages
NMCP only
3 villages
NMCP + LSM
5 villages
NMCP + HI
2 villages
NMCP + HI + LSM
3 villages
NMCP only
2 villages
NMCP + LSM
17 villages
NMCP + HI
3 villages
NMCP + HI + LSM
3 villages
Purposeful selection of 3 Blocks 117 villages excluded
Fig. 4 Flow chart showing the allocation of treatments to villages. HI, house improvement; LSM, larval source management; NMCP, National
Malaria Control Programme
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techniques. Sampling will be conducted at each selected
house one night indoors, and one night outdoors. Field
teams will also collect basic information about the
household through a standardised form. This will in-
clude observations of the types of bed nets in the house,
the use of any insecticides, and the presence of livestock.
Epidemiological data will be collected using a house-
hold survey adapted from the internationally standar-
dised malaria indicator survey (MIS) tool [81]. This tool
includes a core questionnaire covering demographic and
socio-economic aspects of the household and household
members, and an additional module covering malaria
control intervention practices and morbidity indicators.
With written informed consent, a core questionnaire at
household and individual level will be completed. Cover-
age indicators such as ownership and reported use of
ITNs will be collected, regardless of the age of the ITN
users. Data will also be collected on IPTp coverage (for
women aged 15–49 years) and treatment-seeking behav-
iour for fever and ACT use (for children aged 6–
59 months and women aged 15–49 years). Burden indica-
tors will include parasitaemia as measured by RDT (SD
BIOLINE Malaria Ag P.f. HRP-II, Standard Diagnostics,
Yongin-si, Republic of Korea) and anaemia using
HemoCue® Hb 301 (HemoCue, Ängelholm, Sweden) in
children aged 6–59 months and women aged 15–49 years.
For the epidemiological surveys and adult mosquito
sampling, we will use a repeated cross-sectional survey
sampling framework [82]. Every two months from May
2016 through April 2018, 270 households will be se-
lected for the epidemiological survey using a randomized
inhibitory spatial sampling procedure [83]. At the same
time, 195 of those 270 households will be randomly se-
lected for adult mosquito sampling. The lower number
of households for mosquito sampling is necessary be-
cause mosquito traps will be set at each selected house-
hold for two nights, whereas the epidemiological survey
requires one day per household. All households in the
trial villages will be eligible for selection each round re-
gardless of whether they were selected in a previous
round. Data collection at the 270 households will be
conducted over a six-week period, with the last two
weeks of each round reserved for data cleaning.
To determine coverage of HI, the house-level observa-
tions during adult mosquito sampling will also include:
roof type; wall type; window type; open eaves; number
and size of openings; coverage of windows with alumin-
ium screens; and condition of the door. To determine
coverage of LSM, regular monitoring of LSM villages
will be conducted to record the number of potential lar-
val habitats (bodies of standing water) drained and filled
by the community. Larval mosquito populations will be
assessed in all trial villages through regular monitoring
of potential larval habitats. Larval mosquitoes will be
collected using a standardised area sampling method,
where 300 ml dippers and plastic pipettes are used to
collect all Anopheles larvae within a 0.5m2 sampling
quadrat.
A mixture of qualitative and quantitative methods will
be used to collect data on feasibility, acceptability and
appropriateness of the community engagement methods
used. Qualitative methods will include participant obser-
vations, focus group discussions and in-depth interviews.
Quantitative methods will include a cross-sectional stan-
dardised survey to assess knowledge, attitudes and prac-
tices. Economic data will be collected using a societal
perspective and an ingredients approach to assess the
cost and cost-effectiveness of community-implemented
LSM and HI.
Environmental data will also be collected. Weather
stations (HOBO® U30 Station, Onset® Computer Corpor-
ation, Bourne MA, USA) are set up in each of the three
focal areas to collect hourly recordings of temperature,
humidity, rainfall, wind direction and speed, and soil
moisture. Landscape data (e.g. soil type, topography,
land use-land cover, and monthly normalised difference
vegetation index) will be retrieved from publicly-
available sources such as the United States Geological
Survey (USGS) and the International Soil Reference and
Information Centre (ISRIC).
Outcomes
The primary outcome is the estimated entomological in-
oculation rate (EIR) at the end of the intervention
period. The EIR is calculated as the product of the hu-
man biting rate (HBR) and the sporozoite rate (SR),
where HBR is the number of bites from a malaria vector
species per year and SR is the prevalence of the malaria
parasite infective stage (sporozoite) in the local malaria
vector population [84]. Because Suna traps target host-
seeking mosquitoes, the abundance of female malaria
vectors collected per trap-night can be assumed to be
proportional to the number of bites per person per
night. For assessment of the primary outcome: indoor
and outdoor Suna trap samples will be pooled; HBR for
a given village will be calculated as the mean number of
bites per person per night, multiplied by 365; SR will be
calculated as the number of sporozoite-positive malaria
vectors divided by the total number of female malaria
vectors collected in a given village; and EIR will be the
product of HBR and SR. EIR will be calculated by spe-
cies, and then summed across species to get the total
EIR. For primary analysis of the primary outcome, we
will assume every household to be fully covered by the
interventions in the trial arm to which it was allocated
(i.e. assignment of intervention status will be by
intention-to-treat). Data on intervention coverage, col-
lected as described above, will be used in secondary
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analyses of the primary outcome. Secondary outcomes
are shown in Table 3.
Data handling
Tablets will be used for electronic data collection in the
field with entry screens in ODK Collect and OpenHDS.
Following collection by the field team and verification by
a data officer, data will be sent to a central server run-
ning ODK Aggregate and OpenHDS [73] and managed
in respective databases. Database access will be password
protected. The data collection will be managed by the
researchers, working independently from the project
funder and sponsor.
Statistics
The study design described above resulted in the inclu-
sion of 53 villages, distributed as 15, 13 and 25 in focal
areas A, B and C, respectively, with considerable imbal-
ance across treatment categories as shown in Table 4.
For the primary analysis, the outcome measure for each
village is the estimated EIR at the end of the interven-
tion period. Based on evidence from the literature [68,
85, 86] we assume that in the control arm, EIR has a
log-Normal distribution with mean and standard devi-
ation approximately 45 and 14, respectively, giving an ef-
fective range of approximately 0 to 100. We further
assume that a clinically effective intervention will be one
that halves the mean EIR.
The statistical model for the primary analysis will be a
randomised block ANOVA allowing for block effects
plus main effects for each factor and an interaction term.
Because the design is necessarily unbalanced, the esti-
mated effects of the different treatment factors will have
different standard errors. Under standard assumptions,
namely that villages generate statistically independent
outcomes, the resulting power to detect a clinically sig-
nificant main effect of HI, testing at the conventional 5%
level, is 0.669. The associated standard error of the esti-
mated effect size is 0.286. This implies that a 95% confi-
dence interval for the relative reduction in EIR
associated with a clinically significant main effect will
likely extend from 0.285 to 0.876. For the main effect of
LSM, the corresponding figures are 0.728, 0.265 and a
range from 0.298 to 0.840. We have no information on
the possible strength of correlation between results from
villages within the same cluster. To guard against this,
we will test for significance using a robust version of the
ANOVA F-test that respects the restricted randomisation.
Secondary analysis will be conducted at the household
level, to allow for estimation of household-level covariate
effects. We will fit a generalized linear mixed effects
model to each outcome variable, treating village within
focal area as a random effect. Real-valued outcomes will
be analysed under Normal distributional assumptions,
after transformation if necessary. Discrete outcomes will
be analysed using binomial or Poisson distributional as-
sumptions for closed and open counts, respectively, and
including a second-level random effect for households
within villages to allow for over-dispersion. Hence, with
i denoting village, j denoting household within village
and dij a vector of household-level covariates, the linear
Table 3 Outcomes of interest to be analysed
Outcome Metric Source of Data
Entomological inoculation rate
(EIR)*
abundance of female malaria vectors collected per trap-night, multiplied by proportion†
positive for Plasmodium falciparum sporozoites; indoor-only, outdoor-only, and pooled*
Routine monitoring of
adult mosquitoes
Malaria vector community
composition
Ratio† of An. funestus to An. gambiae to An. arabiensis Routine monitoring of
adult mosquitoes
Malaria vector human blood
index (HBI)
Proportion† of Anopheles with human blood in abdomen out of all blood-fed Anopheles Resting mosquito
collections
Peak malaria vector biting time Time of day (starting hour to ending hour) when 80% of host-seeking malaria vectors
collected
Human landing
collections
Larval mosquito density Number of 3rd instar, 4th instar, and pupae per metre of potential larval habitat Routine monitoring of
larval mosquitoes
Parasite prevalence in children
aged 6–59 months
Proportion† of RDT tests positive for Plasmodium falciparum Malaria indicator surveys
Prevalence of anaemia in children
aged 6–59 months
Proportion† of anemia tests with Hb < 8.0 Malaria indicator surveys
Incidence of clinical malaria in
children aged 6–59 months
Number of clinical malaria cases per child per year Incidence study cohorts
*Primary outcome†Raw data for proportions will be stored as separate numbers in the database, with actual proportions calculated at time of
analysis only; also applies to ratios.
Table 4 Number of villages in each trial arm, by focal area
Focal area Control HI LSM HI + LSM Total
A 2 8 2 3 15
B 3 2 5 3 13
C 2 3 17 3 25
Total 7 7 24 9 53
HI house improvements, LSM larval source management
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predictor for the generalized linear model will take the
form
dij βþ Ui þ V ij
where the Ui and Vij are mutually independent, Nor-
mally distributed random variables with means zero and
variances σ2 and τ2, respectively.
We will also conduct a spatio-temporal analysis of any
outcome variable for which the mixed model analysis
identifies an important component of variation at village
and/or household level. This will replace the unstruc-
tured village and/or household level random effects, Ui
and Vij, by a spatio-temporally correlated stochastic pro-
cesses S(x,t) where x and t denote location and time, re-
spectively. It will also use spatially and/or temporally
varying environmental covariates in addition to
household-level covariates identified as important in the
household-level mixed model analyses.
Timetable
Community engagement for the trial started in April
2014 (Fig. 5). Volunteers from all villages were trained as
health animators in September and October 2014 and
started leading fortnightly malaria workshops in their
villages from November 2014, with plans to continue
through to the end of the trial. A community raffle event
was held in each focal area in June 2015 for allocation of
villages to the trial arms. From April 2015 we worked
with the community to develop locally applicable
methods of LSM and HI, which were incorporated into
training curricula for each of the interventions.
Health animators in HI villages were trained on HI in
July 2015, and communities prepared for HI implemen-
tation through September 2015 by forming committees
and preparing materials (e.g. bricks). Implementation of
HI started in October 2015, with the aim of completing
work before the rainy season started. Maintenance of HI
will continue through the end of the trial. Health anima-
tors in LSM villages were trained on LSM in December
2015. Communities began implementing the habitat
modification (draining and filling) part of LSM in Janu-
ary 2015, with continued maintenance planned through
the end of the trial. Training on Bti for health animators
and LSM committees was held in May 2016, with appli-
cation ofBti starting the same month. The trial officially
started on 1 May 2016 with the completion of a mass
distribution of LLINs by the NMCP, ensuring high own-
ership of LLINs throughout the trial catchment area.
Ethical considerations
This study complies with the principles described in the Dec-
laration of Helsinki. This study was approved by the College
of Medicine Research and Ethics Committee (COMREC) in
Malawi (proposal number P.05/15/1731). Written permis-
sion to conduct the study was provided by the District
Health Officer of Chikhwawa District. The WHO Trial
Registration Data Set is given in Additional file 1. The
SPIRIT protocol checklist is given in Additional file 2.
Using the community engagement structures described
above, we informed the communities about the proposed
trial activities and incorporated their feedback where ap-
propriate. Community permission to conduct the trial was
obtained from each village headman verbally, which was
considered a culturally appropriate manner for the per-
mission [87]. Community permission will cover all aspects
of the trial, including the implementation of the proposed
trial interventions and activities for assessment of trial
outcomes. Specifically, community permission will be
considered sufficient for proceeding with the interventions
2014 2015 2016 2017 2018
Activity Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
Enrolment
Community sensitisation
DSS enumeration
Trial arm allocation at community raffle event
Interventions
Training HA on malaria and NMCP interventions
HA-led, 2-weekly malaria workshops
Exploration, testing and curriculum development
Training HA on HI
Community preparations for HI
Community implementation and maintenance of HI
Training HA on LSM
Community implementation of LSM (D/F)
Training HA and LSM committees on Bti
Community implementation of LSM (Bti)
Mass distribution of LLINs by NMCP
Assessments
Pre-trial monitoring and evaluation
Trial monitoring and evaluation
Fig. 5 Trial timeline. The red line indicates the start of the trial. Bti Bacillus thuringiensis israelensis; DSS, demographic surveillance system; D/F,
draining and filling; HA, health animators; HI, house improvement; LSM, larval source management; LLIN, Long-lasting insecticidal nets; NMCP,
National Malaria Control Programme
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as described above. Individual informed consent will not be
sought for the implementation of LSM and HI because the
interventions are implemented at the community level. The
project team has trained community members on the con-
cepts and methods of LSM and HI, but the communities
themselves will actually carry out the vector control activ-
ities. Further, the water bodies that will be affected by LSM
generally belong to the community and not an individual,
per se. Additionally, informed written consent will be
sought from individual participants (and their parents or
guardians if appropriate) during activities for assessment of
entomological and epidemiological outcomes.
The larvicide to be used in this study, Bti, works through
a very specific mode of action, making it unlikely to pose
any hazard to humans or other vertebrates, or to the great
majority of non-target invertebrates [88]. It has been shown
previously to pose no risks to human health when used in
aquatic habitats including drinking-water reservoirs [88].
Discussion
While the use of ITNs and IRS for malaria vector con-
trol has considerably reduced the burden of malaria
across the globe over the last 15 years, calls for eliminat-
ing malaria and management of insecticide resistance
will require additional interventions to be implemented
as part of integrated vector management strategies [89].
Particularly in settings where vector populations are re-
sistant to pyrethroids, or bite outdoors or in the early
evening, ITNs and IRS, which target only indoor-biting
and indoor-resting mosquitoes, will likely be insufficient
as stand-alone interventions to make sustained progress
towards transmission reduction or to drive malaria
transmission to zero [21, 22, 27]. Therefore, this trial is
designed to measure the impact of two vector control
interventions (LSM and HI) on malaria transmission
and burden when implemented in addition to the
Malawi NMCP interventions (LLINs, ACTs and IPTp).
Combining LSM and/or HI together with the interven-
tions currently implemented by the NMCP is anticipated
to reduce malaria transmission below the level reached
by current interventions alone. Both interventions could
also be effective components of an insecticide resistance
management programme by reducing the selective ad-
vantage of pyrethroid resistant individuals in the mos-
quito population.
Implementation of the two interventions, LSM and
HI, is largely delegated to the community. Advantages of
using this community-based as compared to researcher-
based approach to implementation include: implementa-
tion can be done at a larger scale while still being tai-
lored to the local setting; impact is being tested under
more realistic, community-based conditions; and results
will provide insight into the prospects for upscaling and
sustainability.
This community-based approach to implementation is
novel but depends heavily on the compliance of the com-
munity. As researchers, we aim to assure quality of the in-
terventions through monitoring of community workshops
and community activities, through evaluation of coverage
indicators, and through introduction of corrective measures
when and where necessary during the two-year trial. Cor-
rective measures could include additional training for health
animators and committee members, new training methods,
use of local case studies, and instruction through monthly
meetings of health animators and committee members.
We will keep records of these corrective measures, along
with all inputs, processes, outputs and outcomes of
community-based activities as essential components of the
intervention implementation. We will also conduct socio-
behavioural studies to assess the communities’ perceptions
of the approach and economic studies to assess the costs
and cost-effectiveness of this implementation approach.
Additional files
Additional file 1: World Health Organization Trial Registration Data Set
for the MMP LSM/HI trial. (DOCX 117 kb)
Additional file 2: SPIRIT checklist for the MMP LSM/HI trial, indicating which
manuscript page contains each element of the study protocol. (DOC 123 kb)
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